Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
about
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
description
A clinical trial related to cancer immunotherapy, retrieved from clinicaltrials.gov
@en
klinisch onderzoek
@nl
name
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
@en
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
@nl
type
label
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
@en
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
@nl
prefLabel
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
@en
Isatuximab in Treating Patients With High Risk Smoldering Plasma Cell Myeloma
@nl
P1050
P3098
NCT02960555